The present study tested whether SynCav1 gene therapy to Tg AD mice (PSAPP) could preserve MLR-localized fl-TrkB, preserve neuronal and synaptic plasticity, and improve higher brain function. Here, NTRK2 is linked to Alzheimer disease.